Literature DB >> 30252118

A single synonymous mutation determines the phosphorylation and stability of the nascent protein.

Konstantinos Karakostis1, Sivakumar Vadivel Gnanasundram1, Ignacio López1, Aikaterini Thermou1, Lixiao Wang2, Karin Nylander2, Vanesa Olivares-Illana3, Robin Fåhraeus1,2,4.   

Abstract

p53 is an intrinsically disordered protein with a large number of post-translational modifications and interacting partners. The hierarchical order and subcellular location of these events are still poorly understood. The activation of p53 during the DNA damage response (DDR) requires a switch in the activity of the E3 ubiquitin ligase MDM2 from a negative to a positive regulator of p53. This is mediated by the ATM kinase that regulates the binding of MDM2 to the p53 mRNA facilitating an increase in p53 synthesis. Here we show that the binding of MDM2 to the p53 mRNA brings ATM to the p53 polysome where it phosphorylates the nascent p53 at serine 15 and prevents MDM2-mediated degradation of p53. A single synonymous mutation in p53 codon 22 (L22L) prevents the phosphorylation of the nascent p53 protein and the stabilization of p53 following genotoxic stress. The ATM trafficking from the nucleus to the p53 polysome is mediated by MDM2, which requires its interaction with the ribosomal proteins RPL5 and RPL11. These results show how the ATM kinase phosphorylates the p53 protein while it is being synthesized and offer a novel mechanism whereby a single synonymous mutation controls the stability and activity of the encoded protein.
© The Author(s) (2018). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, IBCB, SIBS, CAS. All rights reserved.

Entities:  

Keywords:  ATM kinase; MDM2; cell signaling; intrinsically disordered proteins; p53 messenger RNA; synonymous mutations

Year:  2019        PMID: 30252118      PMCID: PMC6734142          DOI: 10.1093/jmcb/mjy049

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   6.216


  68 in total

Review 1.  Intrinsically unstructured proteins.

Authors:  Peter Tompa
Journal:  Trends Biochem Sci       Date:  2002-10       Impact factor: 13.807

2.  Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.

Authors:  Ian Hickson; Yan Zhao; Caroline J Richardson; Sharon J Green; Niall M B Martin; Alisdair I Orr; Philip M Reaper; Stephen P Jackson; Nicola J Curtin; Graeme C M Smith
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

Review 3.  The interplay between structure and function in intrinsically unstructured proteins.

Authors:  Peter Tompa
Journal:  FEBS Lett       Date:  2005-04-08       Impact factor: 4.124

4.  Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.

Authors:  Shaun P Scott; Regina Bendix; Philip Chen; Raymond Clark; Thilo Dork; Martin F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.

Authors:  Yaron Pereg; Dganit Shkedy; Petra de Graaf; Erik Meulmeester; Marina Edelson-Averbukh; Mogjiborahman Salek; Sharon Biton; Amina F A S Teunisse; Wolf D Lehmann; Aart G Jochemsen; Yosef Shiloh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

6.  Analysis of the degradation function of Mdm2.

Authors:  M H Kubbutat; R L Ludwig; A J Levine; K H Vousden
Journal:  Cell Growth Differ       Date:  1999-02

7.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

Authors:  R Maya; M Balass; S T Kim; D Shkedy; J F Leal; O Shifman; M Moas; T Buschmann; Z Ronai; Y Shiloh; M B Kastan; E Katzir; M Oren
Journal:  Genes Dev       Date:  2001-05-01       Impact factor: 11.361

8.  Phosphorylation site interdependence of human p53 post-translational modifications in response to stress.

Authors:  Shin'ichi Saito; Hiroshi Yamaguchi; Yuichiro Higashimoto; Connie Chao; Yang Xu; Albert J Fornace; Ettore Appella; Carl W Anderson
Journal:  J Biol Chem       Date:  2003-07-14       Impact factor: 5.157

Review 9.  Inhibiting the p53-MDM2 interaction: an important target for cancer therapy.

Authors:  Patrick Chène
Journal:  Nat Rev Cancer       Date:  2003-02       Impact factor: 60.716

10.  Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease.

Authors:  Masatoshi Takagi; Rika Tsuchida; Kaoru Oguchi; Teruko Shigeta; Shinichiro Nakada; Kimiko Shimizu; Misao Ohki; Domenico Delia; Luciana Chessa; Yoichi Taya; Makoto Nakanishi; Yukiko Tsunematsu; Fumio Bessho; Keiichi Isoyama; Yoshiki Hayashi; Kazuko Kudo; Jun Okamura; Shuki Mizutani
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

View more
  11 in total

1.  Synonymous variants that disrupt messenger RNA structure are significantly constrained in the human population.

Authors:  Jeffrey B S Gaither; Grant E Lammi; James L Li; David M Gordon; Harkness C Kuck; Benjamin J Kelly; James R Fitch; Peter White
Journal:  Gigascience       Date:  2021-04-05       Impact factor: 6.524

2.  Codon-specific Ramachandran plots show amino acid backbone conformation depends on identity of the translated codon.

Authors:  Aviv A Rosenberg; Ailie Marx; Alex M Bronstein
Journal:  Nat Commun       Date:  2022-05-20       Impact factor: 17.694

Review 3.  Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes.

Authors:  Nayiri M Kaissarian; Douglas Meyer; Chava Kimchi-Sarfaty
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

Review 4.  The p53 mRNA: an integral part of the cellular stress response.

Authors:  Lucia Haronikova; Vanesa Olivares-Illana; Lixiao Wang; Konstantinos Karakostis; Sa Chen; Robin Fåhraeus
Journal:  Nucleic Acids Res       Date:  2019-04-23       Impact factor: 16.971

5.  p53: updates on mechanisms, biology and therapy (I).

Authors:  David P Lane; Chandra S Verma
Journal:  J Mol Cell Biol       Date:  2019-03-01       Impact factor: 6.216

Review 6.  Molecular and Biochemical Techniques for Deciphering p53-MDM2 Regulatory Mechanisms.

Authors:  Konstantinos Karakostis; Ignacio López; Ana M Peña-Balderas; Robin Fåhareus; Vanesa Olivares-Illana
Journal:  Biomolecules       Date:  2020-12-30

Review 7.  Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets.

Authors:  Alexandros Karagiannakos; Maria Adamaki; Antonis Tsintarakis; Borek Vojtesek; Robin Fåhraeus; Vassilis Zoumpourlis; Konstantinos Karakostis
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

Review 8.  Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?

Authors:  Lucia Haronikova; Ondrej Bonczek; Pavlina Zatloukalova; Filip Kokas-Zavadil; Martina Kucerikova; Philip J Coates; Robin Fahraeus; Borivoj Vojtesek
Journal:  Cell Mol Biol Lett       Date:  2021-12-15       Impact factor: 5.787

9.  The Elephant Evolved p53 Isoforms that Escape MDM2-Mediated Repression and Cancer.

Authors:  Monikaben Padariya; Mia-Lyn Jooste; Ted Hupp; Robin Fåhraeus; Borek Vojtesek; Fritz Vollrath; Umesh Kalathiya; Konstantinos Karakostis
Journal:  Mol Biol Evol       Date:  2022-07-02       Impact factor: 8.800

Review 10.  p53 mRNA Metabolism Links with the DNA Damage Response.

Authors:  Sivakumar Vadivel Gnanasundram; Ondrej Bonczek; Lixiao Wang; Sa Chen; Robin Fahraeus
Journal:  Genes (Basel)       Date:  2021-09-20       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.